What is the recommended management of sepsis in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Sepsis in Pregnancy

Sepsis in pregnancy is a medical emergency requiring immediate initiation of the SEP-1 3-hour bundle: obtain blood cultures, administer broad-spectrum antibiotics within 1 hour, measure lactate, and begin aggressive fluid resuscitation with 1-2 L of balanced crystalloid solution—all while prioritizing maternal stabilization, which will typically stabilize the fetus. 1, 2, 3, 4

Immediate Recognition and Screening (Stage 1-3 Approach)

Use a 3-stage screening framework to identify sepsis early:

  • Stage 1: Initial alert for suspected infection triggers evaluation 1, 2
  • Stage 2: Apply obstetrically modified SIRS (omSIRS) criteria based on gestational age and days postpartum 1, 2
  • Stage 3: Bedside clinical assessment for end-organ injury using pregnancy-modified laboratory criteria 1, 2

Critical diagnostic considerations:

  • Consider sepsis in any pregnant patient with unexplained end-organ damage and suspected infection, regardless of fever presence 3, 4
  • Normal lactate in pregnancy (outside labor) is <2 mmol/L 1, 2
  • Do NOT use lactate to diagnose sepsis during active labor—labor itself, bleeding, hepatic disease, and metformin all elevate lactate independently 1, 2
  • Pregnant patients may appear deceptively well before rapid deterioration to septic shock 1, 5

The 3-Hour Bundle (Immediate Actions)

Within 1-3 hours of sepsis recognition, complete these time-sensitive interventions:

1. Obtain Cultures Before Antibiotics

  • Draw blood cultures from at least two sites 2, 4
  • Obtain urine, respiratory, and other cultures as clinically indicated 3, 4
  • Never delay antibiotics for cultures—if obtaining cultures causes delay, give antibiotics first 2, 4

2. Measure Serum Lactate

  • Obtain initial lactate level for risk stratification 2, 3, 4
  • Lactate ≥4 mmol/L indicates high-risk septic shock requiring 6-hour bundle escalation 1, 2
  • Repeat lactate within 6 hours to assess treatment response 1, 2

3. Administer Antibiotics Immediately

Timing is critical for mortality reduction:

  • Within 1 hour for septic shock or high likelihood of sepsis 1, 2, 3, 4
  • Within 3 hours for suspected infection without shock 1, 2, 4

Recommended antibiotic regimens:

  • First-line: Piperacillin-tazobactam for broad gram-positive, gram-negative, and anaerobic coverage 2
  • Alternative: Ertapenem 2
  • Alternative: Ceftriaxone plus metronidazole 2
  • Traditional obstetric regimen: Gentamicin, clindamycin, and penicillin 5

Pregnancy-specific antibiotic considerations:

  • Higher doses may be needed due to increased renal clearance and expanded volume of distribution in pregnancy 2
  • Plasma antibiotic concentrations are reduced by pregnancy-induced pharmacokinetic changes 2

4. Aggressive Fluid Resuscitation

  • Administer 1-2 L of balanced crystalloid solution (lactated Ringer's or Plasma-Lyte) within the first 3 hours 1, 2, 4
  • Use balanced crystalloids instead of normal saline to avoid hyperchloremic acidosis and acute kidney injury 1, 4
  • Initial rate: 20 mL/kg over the first hour for hypotension or suspected organ hypoperfusion 5, 4

The 6-Hour Bundle (Septic Shock Management)

Escalate to the 6-hour bundle for:

  • Persistent hypotension (MAP <65 mm Hg) after initial fluid resuscitation 1, 2
  • Initial lactate ≥4 mmol/L 1, 2
  • Failure to stabilize with 3-hour bundle interventions 2

Vasopressor Therapy

Norepinephrine is the first-line vasopressor:

  • Start at 0.02 µg/kg/min 1
  • Target MAP ≥65 mm Hg (though not specifically studied in pregnancy) 1, 3, 4
  • Consider invasive arterial blood pressure monitoring 1
  • Can be initiated peripherally until central access is obtained 1

Second-line vasopressor (refractory shock):

  • Add vasopressin 0.04 units/min if MAP remains inadequate despite norepinephrine 0.1-0.2 µg/kg/min 1
  • Theoretical concern about vasopressin-oxytocin receptor interaction, but remains reasonable with fetal monitoring 1

Third-line vasopressor:

  • Consider epinephrine if blood pressure remains inadequate 1

Corticosteroid Therapy

  • Administer hydrocortisone 200 mg/day (50 mg IV every 6 hours or continuous infusion) for patients requiring ongoing vasopressor therapy despite adequate fluid resuscitation 1, 4
  • Initiate after at least 4 hours of vasopressor therapy at ≥0.25 µg/kg/min 1

Ongoing Fluid Management

  • Continue fluid resuscitation using non-invasive hemodynamic monitoring guided by dynamic measures of preload 1, 4
  • Stop fluids when patient stabilizes with decreasing lactate OR pulmonary edema develops 1
  • Reassess volume status and tissue perfusion within 6 hours if hypotension persists or lactate ≥4 mmol/L 1

Pregnancy-Specific Management Priorities

Maternal Stabilization First

The primary objective is expedited maternal evaluation and treatment, which leads to improved uteroplacental perfusion and fetal condition: 1

  • Stabilizing the mother will typically stabilize the fetus 1, 2, 6
  • Do not proceed with emergent delivery for concerning fetal status until maternal stabilization is attempted 5
  • Delivery should be dictated by obstetric indications, not sepsis alone 3
  • Exception: If uterine source is suspected or confirmed, prompt delivery or evacuation achieves source control regardless of gestational age 4

Fetal Surveillance Strategy

Implement continuous fetal heart rate monitoring for dual purposes: 1, 2, 6

  • Assess fetal well-being 1, 2, 6
  • Guide maternal resuscitation efforts—fetal surveillance provides real-time measure of maternal end-organ perfusion 1, 2, 6

Management of non-reassuring fetal tracings:

  • Fetal heart rate tracings may be expectantly managed during initial maternal stabilization 1, 6
  • Most tracings improve with maternal hemodynamic optimization 1, 6
  • Use multidisciplinary team approach considering infection source, gestational age, maternal/fetal health, and patient preferences 1

Optimize Uteroplacental Perfusion

Positioning:

  • Maintain lateral positioning in patients beyond 20 weeks gestation to reduce aortocaval compression and improve blood flow 2, 6

Temperature control:

  • Control maternal fever to reduce fetal oxygen consumption and prevent fetal tachycardia 2, 6

Glycemic control:

  • Initiate insulin therapy for persistent hyperglycemia >180 mg/dL 2
  • Target glucose range 140-180 mg/dL 2
  • Maternal hyperglycemia causes fetal hyperglycemia, acidosis, decreased uterine blood flow, and lower fetal oxygenation 2, 6

Hemodynamic targets:

  • Maintain MAP ≥65 mm Hg to ensure adequate uteroplacental perfusion 2, 6

Source Control and Infection Management

Rapidly identify and control the anatomic source of infection:

  • Perform thorough physical examination and imaging to identify septic source 5, 4
  • Surgical excision of septic foci (abscess, necrotic tissue) is essential—patients may continue to deteriorate despite appropriate antibiotics without source control 5
  • Consider empiric exploratory laparotomy if source remains unclear 5
  • For suspected uterine source, prompt delivery or evacuation of uterine contents achieves source control 4

Transfer and Escalation of Care

Transfer criteria requiring multidisciplinary team decision:

  • Persistent hypotension (MAP <65 mm Hg) 1, 2
  • Need for vasopressors 1, 2
  • Persistent hypoxia (oxygen saturation <92% on room air) 1
  • Altered mental status 1
  • Lactate ≥4 mmol/L 1, 2

Appropriate care location:

  • Transfer to level 3 or 4 care center for pregnant patients with sepsis 1, 2
  • Level 2 centers with ICU services capable of caring for pregnant/postpartum patients may be acceptable 1

Transfer logistics:

  • Stabilize patient before transport 1, 2
  • If delivery is imminent, postpone transfer until after childbirth 1
  • Do not delay transport due to inability to monitor fetus—maternal stabilization is priority 1, 2

Additional Critical Interventions

Venous Thromboembolism Prophylaxis

  • Administer pharmacologic VTE prophylaxis to all patients without contraindications 1, 4
  • Low-molecular-weight heparin is preferred 1
  • VTE risk in septic patients reported as high as 37% 1

Oxygenation

  • Ensure adequate maternal oxygenation to optimize uteroplacental oxygen delivery 2
  • Monitor oxygen saturation continuously 1

Common Pitfalls to Avoid

Diagnostic pitfalls:

  • Do not dismiss nonspecific symptoms in at-risk patients—pregnant women may endure sepsis challenges longer but deteriorate rapidly 1, 5
  • Do not use lactate alone during labor to diagnose sepsis 1, 2
  • Do not wait for fever—sepsis can occur without fever 3, 4

Management pitfalls:

  • Do not delay antibiotics to obtain cultures if cultures cause delay 2, 4
  • Do not delay maternal stabilization for fetal monitoring concerns 1, 2
  • Do not proceed with emergent delivery before attempting maternal stabilization unless uterine source is confirmed 3, 5, 4
  • Do not use normal saline—use balanced crystalloids 1, 4
  • Do not use starches or gelatin for resuscitation 4

Transfer pitfalls:

  • Do not delay transport due to inability to monitor fetus 1, 2
  • Do not transfer unstable patients—stabilize first 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Suspected Sepsis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

SMFM Consult Series #47: Sepsis during pregnancy and the puerperium.

American journal of obstetrics and gynecology, 2019

Research

Society for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis.

American journal of obstetrics and gynecology, 2023

Research

Severe sepsis and septic shock in pregnancy.

Obstetrics and gynecology, 2012

Guideline

Risk of Fetal Sepsis from Maternal Urosepsis in Third Trimester

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is a proposed prevention strategy for maternal sepsis in pregnant women?
What is the recommended broad-spectrum antibiotic regimen for suspected sepsis in pregnancy?
What is the risk of fetal sepsis in a mother with urosepsis in the third trimester?
What is the management of suspected sepsis in pregnancy?
What are the diagnostic criteria and management for sepsis in the puerperal (postpartum) period?
What are the changes in the diagnosis of alcohol‑related disorders across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR (Text Revision), IV, V, and V‑TR (Text Revision), and the International Classification of Diseases (ICD) versions X and XI?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‑5‑TR) and the International Classification of Diseases, Eleventh Revision (ICD‑11) in diagnosing alcohol‑related disorders?
What is the optimal sedation strategy for a ventilated patient with hepatic encephalopathy and respiratory failure?
What oral medication is recommended as the safest initial treatment for an unspecified rash?
A patient’s arterial blood gas shows pH (potential of hydrogen) 7.30, pCO2 (partial pressure of carbon dioxide) 30 mm Hg, HCO3 (bicarbonate) 19 mEq/L, and pO2 (partial pressure of oxygen) 80 mm Hg. What is the acid–base disorder?
What are the diagnostic changes for cannabis‑related disorders across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR, IV, V, and V‑TR, and the International Classification of Diseases (ICD) versions X and XI?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.